Aurora Cannabis Inc. - Common Shares (NQ:ACB)

4.080 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 29, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Aurora Cannabis Inc. - Common Shares

< Previous 1 2 3 4 5 6 7 8 9

...

49 50 Next >

MarketBeat Week in Review – 10/19 - 10/23 ↗

October 24, 2026

A market sell-off spread beyond tech as oil prices surged and AI concerns grew. MarketBeat analysts recap the week's top stories on earnings, from Halliburton to Meta Platforms and General Motors.

Via MarketBeat

Topics Artificial Intelligence Economy

Aurora Rejects Curaleaf's Higher Bid, But the Takeover Fight Isn't Over ↗

October 20, 2026

Curaleaf raised its hostile bid for Aurora Cannabis to about $5 per share, citing a 217% ex-cash premium, as the two cannabis firms clash over board access and valuation.

Via MarketBeat

Topics Cannabis Economy

Aurora Cannabis Stock Has Soared 25% Since Curaleaf First Made an Offer to Buy Its Business. Here's Why I Think It Can Go Even Higher ↗

October 12, 2026

Curaleaf looks eager to buy Aurora Cannabis, and that's helped to drive its value up.

Via The Motley Fool

Topics Cannabis

Cannabis Stocks Aren’t a Recovery Trade: Narrow Leadership Splits Quality and Momentum ↗

October 06, 2026

Via Chartmill

Topics Cannabis

Small-Cap Cannabis Stocks Surge, but Big-Cap Laggards Reveal a Narrow, Speculative Rally ↗

August 14, 2026

Via Chartmill

Topics Cannabis

Tilray Finds a Path to Growth Without Waiting on U.S. Cannabis Reform ↗

October 09, 2026

Tilray Brands' fiscal Q1 2027 results show beverage revenue up 82% and European medical cannabis growth offsetting weaker Canadian sales, reducing reliance on U.S. federal rescheduling.

Via MarketBeat

Topics Cannabis

Curaleaf’s Higher Aurora Bid Raises the Stakes in Cannabis Consolidation ↗

October 06, 2026

Curaleaf has raised its hostile bid for Aurora Cannabis to $5 per share as Schedule III tax relief fuels cannabis M&A, with Tilray's Oct. 8 earnings seen as a sector barometer.

Via MarketBeat

Topics Cannabis ETFs

Curaleaf's Hostile Takeover Attempt of Aurora Cannabis Is Hitting Turbulence. Here's What Investors Should Watch. ↗

September 26, 2026

Hostile takeovers are called hostile for a reason, and this one is getting ugly.

Via The Motley Fool

Topics Cannabis

Curaleaf Tries To Roll Up Aurora In a Hostile Cannabis Bid ↗

September 15, 2026

Curaleaf took a hostile, $4-per-share cash-and-stock tender offer for Aurora Cannabis directly to shareholders after private merger talks stalled, seeking global scale ahead of federal cannabis...

Via MarketBeat

Topics Cannabis

Should You Buy Canopy Growth Stock on the Rebound? ↗

September 05, 2026

Canopy Growth benefited from growth across all its divisions in the first quarter of fiscal 2027, but does that make it a worthwhile investment?

Via The Motley Fool

Topics Cannabis

Is Aurora Cannabis Stock a Buy as Curaleaf Pushes a Hostile Takeover Bid? ↗

August 28, 2026

Aurora's turnaround could make Curaleaf's offer look too low.

Via The Motley Fool

Topics Cannabis

The Cannabis M&A Wave Is Here. Curaleaf Proved It. Here's Whether Green Thumb Should Ride It -- or Wait to Be Swept Up. ↗

August 23, 2026

Green Thumb Industries is in a strong position to acquire other cannabis companies, but will that happen?

Via The Motley Fool

Topics Cannabis

Curaleaf's Hostile Takeover Bid for Aurora Is Just the Tip of the Iceberg for Cannabis Consolidation. These 2 Stocks Could Be the Biggest Winners. ↗

August 21, 2026

After a huge gold rush, the marijuana sector stumbled, and now consolidation is gaining momentum.

Via The Motley Fool

Topics Cannabis

Is Curaleaf Stock a Buy With Its Attempted Hostile Takeover of Aurora Cannabis Under Way? ↗

August 20, 2026

The U.S. company formally kicked off the bid for its peer across the northern border.

Via The Motley Fool

Topics Cannabis

Curaleaf Wants to Buy Aurora Cannabis for $272 Million. Is Canopy Growth the Next Marijuana Takeover Target? ↗

August 16, 2026

Cannabis consolidation appears to be accelerating.

Via The Motley Fool

Topics Cannabis

Joint Operations: Curaleaf Makes a Play for Aurora Cannabis ↗

August 14, 2026

Curaleaf's unsolicited $272 million tender offer for Aurora Cannabis targets EU-GMP cultivation capacity, with Aurora's board forming a special committee to evaluate the cash-and-stock bid.

Via MarketBeat

Topics Cannabis

Will Canopy Growth Get Acquired? ↗

August 13, 2026

Curaleaf is attempting to acquire Canopy Growth's rival, Aurora Cannabis, and there could be more consolidation to come in the industry.

Via The Motley Fool

Topics Cannabis

Is Acquiring Aurora Cannabis a Good Move for Curaleaf? ↗

August 12, 2026

Aurora Cannabis would expand Curaleaf's international presence, but it hasn't been a strong business in recent years.

Via The Motley Fool

Topics Cannabis

Aurora Cannabis (ACB) Q1 2027 Earnings Call Transcript ↗

August 12, 2026

German market expansion drove $43M in international medical cannabis revenue amid Canadian pricing pressure.

Via The Motley Fool

Topics Cannabis Earnings

Curaleaf Just Announced a Hostile Takeover Bid for Aurora Cannabis. Here’s What This Means for Investors. ↗

August 12, 2026

It's appealing directly to the Canadian company's shareholders with a cash-and-stock offer.

Via The Motley Fool

Topics Cannabis

Aurora Cannabis Shareholders Approve Board as Fiscal 2026 Results Beat Outlook ↗

August 07, 2026

Aurora Cannabis (NASDAQ:ACB) said shareholders approved all items presented at its annual general meeting, including setting the board size at five directors, electing the company’s nominees,...

Via MarketBeat

Topics Cannabis

Aurora Cannabis Q1 Earnings Call Highlights ↗

August 05, 2026

Aurora Cannabis (NASDAQ:ACB) reported fiscal first-quarter 2027 net revenue of C$67.6 million, as growth in international medical cannabis sales was offset by lower Canadian medical revenue following...

Via MarketBeat

Topics Cannabis Earnings

Aurora (ACB) Q4 2026 Earnings Transcript ↗

June 11, 2026

Aurora (ACB) Q4 2026 Earnings Transcript

Via The Motley Fool

Topics Cannabis

Aurora Cannabis Q4 Earnings Call Highlights ↗

June 11, 2026

Aurora Cannabis (NASDAQ:ACB) reported a stronger fiscal 2026 performance than it had forecast, driven by growth in global medical cannabis, while warning that fiscal 2027 will be a “reset year” as...

Via MarketBeat

Topics Cannabis Earnings

The 420 Failure: Here's the Real Reason Tilray Brands Has Been a Horrible Investment Despite Operating in a Legal Marijuana Market ↗

April 20, 2026

The cannabis stock has lost around 96% of its value over the past five years.

Via The Motley Fool

Topics Cannabis

Tilray Brands Reports Record Q3 2026 Results: A Deep Dive into the $207 Million Revenue Milestone

April 06, 2026

Tilray Brands (NASDAQ:TLRY) has officially transitioned from a volatile cannabis producer to a diversified global consumer packaged goods (CPG) powerhouse, reporting record-breaking Q3 fiscal 2026...

Via MarketMinute

Topics Cannabis Earnings Economy

Tilray Surges on Record Revenue and Global Expansion Despite Third-Quarter Earnings Miss

April 01, 2026

In a paradoxical display of market confidence, shares of Tilray Brands (NASDAQ:TLRY) surged over 8% on Wednesday following the release of its fiscal third-quarter 2026 financial results. While the...

Via MarketMinute

Topics Cannabis Earnings

Is Aurora Cannabis Stock Ready to 10X in the Next Pot Boom? ↗

February 26, 2026

Is it finally time to consider this beaten-down stock?

Via The Motley Fool

Topics Cannabis Government Law Enforcement

Aurora Cannabis (ACB) Q3 2026 Earnings Transcript ↗

February 04, 2026

Aurora Cannabis (ACB) Q3 2026 Earnings Transcript

Via The Motley Fool

Topics Cannabis

Do These 2 Cannabis Stocks Have a Future? ↗

December 28, 2025

Don't get your hopes up.

Via The Motley Fool

Topics Cannabis Government Law Enforcement

< Previous 1 2 3 4 5 6 7 8 9

...

49 50 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.